NCT07739745

Brief Summary

The goal of this study is to develop an online educational tool that we can make widely available to broader patient community.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
66mo left

Started Jan 2027

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2027

Expected
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2030

2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2032

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

3.4 years

First QC Date

July 28, 2026

Last Update Submit

July 28, 2026

Conditions

Endometrial Cancer

Outcome Measures

Primary Outcomes (1)

  • Safety and Adverse Events (AEs)

    Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

    Through study completion; an average of 1 year

Study Arms (2)

Healthcare Providers

EXPERIMENTAL

Healthcare providers will be recruited from MD Anderson Cancer Center and outside institutions to reflect a broad group of physicians

Other: Interactive Educational Website

Patients

EXPERIMENTAL

Participants will be recruited from the University of Texas MD Anderson Cancer Center (MDA), MDA Houston Area Locations (HALs), and The Harris Health System (LBJ).

Other: Interactive Educational Website

Interventions

Interactive Educational WebsiteOTHER

Participants will utilize website to access educational content, knowledge measure, values survey, and cognitive and usability testing

Healthcare ProvidersPatients

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients:
  • Study Objective 1 (Part A-C see Figure 2)
  • Women who have been diagnosed with endometrial cancer
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent
  • Study Objectives 2 and 3 (Pilot Study)
  • Women who have been diagnosed with endometrial cancer who are or will be receiving systemic treatment
  • Must be at least 18 years old
  • Must read and speak English or Spanish
  • Must provide written informed consent.
  • Physicians:
  • Study Objective 1 (Qualitative Interviews)
  • Gynecologic oncologists or medical oncologists who practice at MDA or outside institutions
  • Must be able to speak and read English
  • +6 more criteria

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UT MD Anderson

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Endometrial Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Larissa Meyer, MD, MPH

    UT MD Anderson

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Larissa Meyer, MD, MPH

CONTACT

(713) 745-0973lmeyer@mdanderson.org

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2026

First Posted

July 31, 2026

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

June 1, 2030

Study Completion (Estimated)

June 1, 2032

Last Updated

July 31, 2026

Record last verified: 2026-07

Locations

US(1)